Combined Prevention of Thrombosis and Hemorrhagic Complications in Patients after Replacement of the Knee or Hip Joint

Abstract

The article demonstrates the importance of observing the time interval between hemostatic and anticoagulant therapy for at least 18 hours, particularly when using tranexamic acid as a hemostatic drug. The developed complications of a thrombotic and hemorrhagic nature in the early postoperative period after knee and hip arthroplasty were analyzed. Schemes of hemostatic and anticoagulant agents, which developed thrombosis and hemorrhagic complications, were also determined.